Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | GRM5 | P41594 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CCR1 | P32246 | 1/20 | 0.46 |
| ▸ | CCR5 | P51681 | 1/20 | 0.46 |
| ▸ | CCR8 | P51685 | 1/20 | 0.46 |
| ▸ | METAP1 | P53582 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.46 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15874590 | 0.86 | ALDH1A1 (0.61) | ALDH1A1TDP1MAOBGRM5ACHE | |
| SCHEMBL5006757 | 0.85 | ALDH1A1 (0.46) | ALDH1A1TDP1GRM5PDE10APOLB | |
| SCHEMBL15365995 | 0.85 | F12 (0.46) | ALDH1A1TDP1GRM5ACHEPDE10A | |
| SCHEMBL28913472 | 0.84 | ALDH1A1 (0.49) | ALDH1A1PDE10APOLBLMNAKDM4E | |
| SCHEMBL4150422 | 0.83 | PDE10A (0.53) | ALDH1A1TDP1PDE10APOLBLMNA | |
| SCHEMBL30117516 | 0.83 | PDE10A (0.53) | ALDH1A1TDP1PDE10APOLBLMNA | |
| SCHEMBL12938251 | 0.82 | ALDH1A1 (0.51) | ALDH1A1TDP1MAOBGRM5ACHE | |
| SCHEMBL11046684 | 0.82 | MEN1 (0.56) | ALDH1A1TDP1GRM5ACHELMNA | |
| SCHEMBL31599140 | 0.82 | MEN1 (0.56) | ALDH1A1TDP1GRM5ACHELMNA | |
| SCHEMBL28653396 | 0.82 | PDE10A (0.45) | ALDH1A1TDP1MAOBGRM5ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6558650-B1 | Exposing tumor cells to a nifedipine photodegradation product; | OREGON HEALTH AND SCIENCE UNIVERSITY | 2003-05-06 | — | — | US | claimed |
| EP-1069918-A4 | ENHANCEMENT OF CELLULAR GALLIUM UPTAKE | UNIV OREGON HEALTH SCIENCES (US) | 2002-02-20 | — | — | EP | claimed |
| EP-1069918-A1 | ENHANCEMENT OF CELLULAR GALLIUM UPTAKE | Oregon Health Sciences University (US) | 2001-01-24 | — | — | EP | claimed |
| WO-1999051277-A1 | ENHANCEMENT OF CELLULAR GALLIUM UPTAKE | OREGON HEALTH SCIENCES UNIVERSITY (US) | 1999-10-14 | — | — | WO | claimed |
| US-12440482-B2 | 1,4-dihydropyridine compositions, methods of making and use | AMERICAN REGENT, INC. (US) | 2025-10-14 | — | — | US | disclosed |
| US-12043730-B2 | Fused deposition modeling type additive manufacturing material | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-07-23 | — | — | US | disclosed |
| CN-118239988-A | Preparation method and application of heterochiral binuclear Ir (III) metal-organic double-helix structure compound | 大连理工大学 | 2024-06-25 | — | — | CN | disclosed |
| EP-3238711-B1 | BASE FOR SOLID DISPERSION, PRODUCTION METHOD FOR SOLID DISPERSION USING SAME, AND SOLID DISPERSION | MITSUBISHI CHEM CORP (JP) | 2023-07-12 | — | — | EP | disclosed |
| EP-3831879-B1 | MATERIAL FOR FUSED DEPOSITION MODELING TYPE ADDITIVE MANUFACTURING | MITSUBISHI CHEM CORP (JP) | 2023-07-12 | — | — | EP | disclosed |
| EP-4032527-A1 | STABLE NIMODIPINE PARENTERAL FORMULATION | Grace Therapeutics Inc. (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-3442586-B1 | STABLE NIMOPIDINE PARENTERAL FORMULATION | Grace therapeutics Inc (US) | 2022-06-08 | — | — | EP | disclosed |
| US-20220016097-A1 | 1,4-DIHYDROPYRIDINE COMPOSITIONS, METHODS OF MAKING AND USE | AMERICAN REGENT, INC. (US) | 2022-01-20 | — | — | US | disclosed |
| WO-2000066563-A1 | IMIDAZOLINE DERIVATIVES AS ALPHA-1A ADRENOCEPTOR LIGANDS | GLAXO GROUP LIMITED (GB) | 2000-11-09 | — | — | WO | disclosed |
| EP-0998304-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLODEXTRINS | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-05-10 | — | — | EP | disclosed |
| WO-1999010346-A1 | BENZOTHIADIAZINYL-INDOLE DERIVATIVES AND THEIR USE AS SEROTONIN RECEPTOR LIGANDS | ELI LILLY AND COMPANY LIMITED (GB) | 1999-03-04 | — | — | WO | disclosed |
| WO-1998055148-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLODEXTRINS | JANSSEN PHARMACEUTICA N.V. (BE) | 1998-12-10 | — | — | WO | disclosed |
| US-5534440-A | ISOTHIOCYANATE, IONIZABLE GROUP | BIOMEDICAL RESEARCH CENTRE LIMITED (CA) | 1996-07-09 | — | — | US | disclosed |
| US-4886822-A | SIDE EFFECT REDUCTION | KOWA COMPANY, LTD. (JP) | 1989-12-12 | — | — | US | disclosed |
| EP-0286979-A1 | Substituted anilide derivatives | KOWA COMPANY, LTD. (JP) | 1988-10-19 | — | — | EP | disclosed |
| US-4502995-A | Nucleophilic substitution process | ETHYL CORPORATION (US) | 1985-03-05 | — | — | US | disclosed |